Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to demonstrate that Askina® Calgitrol® Paste is safe to use on III degree burns by quantifying the concentration of silver in the blood during treatment and thus to show that the amount of silver absorbed will be no greater than those reported in the literature.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT01911858
Study type Interventional
Source BBraun Medical SAS
Contact
Status Withdrawn
Phase Phase 3
Start date April 2013

See also
  Status Clinical Trial Phase
Terminated NCT01715012 - Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts Phase 2
Completed NCT02285517 - Comparing Modified Meek and Mesh Techniques N/A